OBIO
Orchestra BioMed Holdings Inc.
5.70$
-3.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.4% | +2.8% | +0.0% | +2.7% | +10.5% | -1.2% | -2.4% | +0.0% | +1.2% | +9.8% | +6.7% | – | |
| – | -73.8% | +181.6% | +6.7% | -14.4% | +22.8% | +2.2% | +9.6% | -7.3% | -8.7% | +3.7% | -12.1% | – | |
| – | -118.9% | – | – | -140.3% | – | – | – | +609.8% | -583.3% | – | – | – | |
| – | -84.2% | +166.7% | +1,237.5% | -36.4% | +55.9% | +5.7% | -69.6% | +811.8% | -89.4% | +457.6% | +38.0% | – | |
| – | +156.1% | -82.3% | +77.9% | -94.7% | -773.8% | – | +25.8% | -335.9% | -54.1% | – | -325.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -267,500.0% | – | +850.0% | +8,692.4% | -7.2% | -102.1% | +44.6% | – | -83.4% | -56.3% | +528.7% | – | |
| – | +330.2% | -163.0% | – | +386.4% | -276.7% | – | – | +5,701.2% | -131.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.